Literature DB >> 23254150

An evaluation of the President's Emergency Plan for AIDS Relief effect on health systems strengthening in sub-Saharan Africa.

Robert L Cohen1, Yuanzhang Li, Russell Giese, James D Mancuso.   

Abstract

BACKGROUND: President's Emergency Plan for AIDS Relief (PEPFAR) has been criticized for its vertical or "stove-piping" structure, with resources targeting a specific disease rather than working to strengthen the underlying health system. This study aimed to evaluate whether PEPFAR activities were associated with system-wide improvements in both proximal and distal indicators of health systems strengthening.
METHODS: The World Bank database provided 12 indicators of health systems strengthening that were analyzed for their relationship to PEPFAR. Poisson and linear regression models were used to estimate the time trend. We evaluated the PEPFAR impact on health outcomes by comparing the time trend in each of the above indicators between 2 time periods: from 1995 to 2002 (pre-PEPFAR) and from 2004 to 2010 (during PEPFAR).
RESULTS: PEPFAR activities showed strong and statistically significant associations with improvements in proximal indicators of health systems strengthening, those related directly to HIV, specifically life expectancy (P = 0.003) and tuberculosis incidence, prevalence, and mortality (P < 0.0001). There were nonsignificant associations between PEPFAR and improvements in distal indicators of health systems strengthening, namely infant mortality and under 5 child mortality.
CONCLUSIONS: The progressive scale-up of PEPFAR-supported activities was associated with consistent improvements in proximal indicators of health systems strengthening. It was also associated with improvements in broader measures of health system strength, most clearly life expectancy. Given the limited number of health measures available for this type of analysis, more data must be collected for other indicators to evaluate the effectiveness of the many multibillion dollar global health initiatives.

Entities:  

Mesh:

Year:  2013        PMID: 23254150     DOI: 10.1097/QAI.0b013e3182816a86

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Implementation of a health management mentoring program: year-1 evaluation of its impact on health system strengthening in Zambézia Province, Mozambique.

Authors:  Laura J Edwards; Abú Moisés; Mathias Nzaramba; Aboobacar Cassimo; Laura Silva; Joaquim Mauricio; C William Wester; Sten H Vermund; Troy D Moon
Journal:  Int J Health Policy Manag       Date:  2015-03-12

2.  The impact of external donor support through the U.S. President's Emergency Plan for AIDS Relief on the cost of red cell concentrate in Namibia, 2004-2011.

Authors:  John P Pitman; Adele Bocking; Robert Wilkinson; Maarten J Postma; Sridhar V Basavaraju; Bjorn von Finckenstein; Mary Mataranyika; Anthony A Marfin; David W Lowrance; Cees Th Smit Sibinga
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  Did PEPFAR investments result in health system strengthening? A retrospective longitudinal study measuring non-HIV health service utilization at the district level.

Authors:  Samuel Abimerech Luboga; Bert Stover; Travis W Lim; Frederick Makumbi; Noah Kiwanuka; Flavia Lubega; Assay Ndizihiwe; Eddie Mukooyo; Erin K Hurley; Nagesh Borse; Angela Wood; James Bernhardt; Nathaniel Lohman; Lianne Sheppard; Scott Barnhart; Amy Hagopian
Journal:  Health Policy Plan       Date:  2016-03-27       Impact factor: 3.344

Review 4.  HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?

Authors:  Emily P Hyle; Kogieleum Naidoo; Amanda E Su; Wafaa M El-Sadr; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 5.  Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Authors:  Wilfred Ngwa; Beatrice W Addai; Isaac Adewole; Victoria Ainsworth; James Alaro; Olusegun I Alatise; Zipporah Ali; Benjamin O Anderson; Rose Anorlu; Stephen Avery; Prebo Barango; Noella Bih; Christopher M Booth; Otis W Brawley; Jean-Marie Dangou; Lynette Denny; Jennifer Dent; Shekinah N C Elmore; Ahmed Elzawawy; Diane Gashumba; Jennifer Geel; Katy Graef; Sumit Gupta; Serigne-Magueye Gueye; Nazik Hammad; Laila Hessissen; Andre M Ilbawi; Joyce Kambugu; Zisis Kozlakidis; Simon Manga; Lize Maree; Sulma I Mohammed; Susan Msadabwe; Miriam Mutebi; Annet Nakaganda; Ntokozo Ndlovu; Kingsley Ndoh; Jerry Ndumbalo; Mamsau Ngoma; Twalib Ngoma; Christian Ntizimira; Timothy R Rebbeck; Lorna Renner; Anya Romanoff; Fidel Rubagumya; Shahin Sayed; Shivani Sud; Hannah Simonds; Richard Sullivan; William Swanson; Verna Vanderpuye; Boateng Wiafe; David Kerr
Journal:  Lancet Oncol       Date:  2022-05-09       Impact factor: 54.433

Review 6.  A Human-Centered Approach to CV Care: Infrastructure Development in Uganda.

Authors:  Christopher T Longenecker; Ankur Kalra; Emmy Okello; Peter Lwabi; John O Omagino; Cissy Kityo; Moses R Kamya; Allison R Webel; Daniel I Simon; Robert A Salata; Marco A Costa
Journal:  Glob Heart       Date:  2018-04-21

7.  Association of the US President's Emergency Plan for AIDS Relief's Funding With Prevention of Mother-to-Child Transmission of HIV in Kenya.

Authors:  Dale A Barnhart; Isaac Tsikhutsu; Duncan Kirui; Fredrick Sawe; Jane Muli; William Sugut; Nareen Abboud; Deborah Birx; Tiffany Hamm; Peter Coakley; Patrick W Hickey; Vanessa Wolfman; Elizabeth Lee; Donna Spiegelman
Journal:  JAMA Netw Open       Date:  2019-09-04

8.  Financing HIV programming: how much should low- and middle-income countries and their donors pay?

Authors:  Omar Galárraga; Veronika J Wirtz; Yared Santa-Ana-Tellez; Eline L Korenromp
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

9.  The survival benefits of antiretroviral therapy in South Africa.

Authors:  Michael D April; Robin Wood; Bethany K Berkowitz; A David Paltiel; Xavier Anglaret; Elena Losina; Kenneth A Freedberg; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.